| 書目名稱 | Resistance to Molecular Therapies for Hepatocellular Carcinoma |
| 編輯 | Augusto Villanueva |
| 視頻video | http://file.papertrans.cn/829/828455/828455.mp4 |
| 概述 | This book will evaluate the clinical patterns of resistance to sorafenib, the impact of trial design in the second-line setting and the current gold-standard to define radiological resistance.This boo |
| 叢書名稱 | Resistance to Targeted Anti-Cancer Therapeutics |
| 圖書封面 |  |
| 描述 | .This volume evaluates the clinical patterns of resistance to sorafenib, the impact of trial design in the second-line setting and the current gold standard to define radiological resistance; describes the molecular mechanisms responsible for treatment resistance in HCC patients, including components of the immune system and tumor microenvironment; determines the role of the cancer stem cell phenotype in resistance; reviews the experimental models to study resistance; and addresses new approaches to overcome resistance to sorafenib, using successful examples from other malignancies.?. . |
| 出版日期 | Book 2017 |
| 關(guān)鍵詞 | Cancer stem cell phenotype; Carcinoma; Hapatocellular Carcinoma; Liver cancer; Sorafenib |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-319-56197-4 |
| isbn_softcover | 978-3-319-85850-0 |
| isbn_ebook | 978-3-319-56197-4Series ISSN 2196-5501 Series E-ISSN 2196-551X |
| issn_series | 2196-5501 |
| copyright | Springer International Publishing AG 2017 |
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-11 17:16
發(fā)表于 2025-3-21 18:31:23
